Correction to “Soluble urokinase plasminogen activator receptor and interleukin‐6 improve prediction of all‐cause mortality and major adverse cardiovascular events in Type 1 diabetes”
Abstract
The authors confirm that these corrections do not alter the study's main findings, interpretations, or conclusions.We apologize for these errors.
Fields of Study & Subjects
Diabetes Management and Research
Diabetes
Cardiovascular Risks
and Lipoproteins
Adipokines
Inflammation
and Metabolic Diseases
Publication details
- Journal / source
- Journal of Internal Medicine
- Volume
- 299
- Issue
- 4
- Pages
- 534–536
- Publication date
- 14 January 2026
- Language
- EN